SCHEMBL3962287

SCHEMBL3962287

COc1ccc(C(=O)c2ccc(C(F)(F)F)cc2)cc1OC

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.71
CYP2C19 P33261 2/20 0.71
CYP3A4 P08684 1/20 0.71
CYP2C9 P11712 1/20 0.71
TSHR P16473 1/20 0.71
ALDH1A1 P00352 3/20 0.66
GAA P10253 2/20 0.66
MAPT P10636 1/20 0.56
CA12 O43570 1/20 0.54
CA1 P00915 1/20 0.54
CA2 P00918 1/20 0.54
CA4 P22748 1/20 0.54
CA6 P23280 1/20 0.54
CA7 P43166 1/20 0.54
TPMT P51580 1/20 0.54
CA9 Q16790 1/20 0.54
CA14 Q9ULX7 1/20 0.54
SRD5A2 P31213 1/20 0.54
ACHE P22303 4/20 0.54
TUBB4A P04350 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1962189 0.89 CYP1A2 (0.69) CYP1A2CYP2C19CYP3A4CYP2C9TSHR
SCHEMBL25688106 0.88 CYP1A2 (0.53) CYP1A2CYP2C19CYP3A4CYP2C9TSHR
SCHEMBL7367773 0.88 SLC22A6 (0.73) CYP1A2CYP2C19CYP3A4CYP2C9TSHR
SCHEMBL9929088 0.86 CYP1A2 (0.65) CYP1A2CYP2C19CYP3A4CYP2C9TSHR
SCHEMBL9364577 0.86 CYP1A2 (0.96) CYP1A2CYP2C19CYP3A4CYP2C9TSHR
SCHEMBL8514183 0.85 CYP1A2 (0.73) CYP1A2CYP2C19CYP3A4CYP2C9TSHR
SCHEMBL1493250 0.84 CYP1A2 (1.00) CYP1A2CYP2C19CYP3A4CYP2C9TSHR
SCHEMBL25688156 0.84 CYP1A2 (0.49) CYP1A2CYP2C19CYP3A4CYP2C9TSHR
SCHEMBL15988925 0.83 CTNNB1 (0.68) CYP1A2CYP2C19CYP3A4CYP2C9TSHR
SCHEMBL7368681 0.83 NPC1 (0.62) ACHEBCHENPC1SMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4692072-A1 PHOTOCHROMIC COMPOUND, PROPARGYL ALCOHOL COMPOUND, CURABLE COMPOSITION, OPTICAL ARTICLE, LENS, AND SPECTACLES TOKUYAMA CORPORATION (JP) 2026-02-11 EP disclosed
US-12344617-B2 Indolonaphthopyrans TRANSITIONS OPTICAL, LTD. (IE) 2025-07-01 US disclosed
CN-113227098-B Indolonaphthopyrans 光学转变有限公司 2025-01-07 CN disclosed
WO-2024202087-A1 PHOTOCHROMIC COMPOUND, PROPARGYL ALCOHOL COMPOUND, CURABLE COMPOSITION, OPTICAL ARTICLE, LENS, AND SPECTACLES 株式会社トクヤマ 2024-10-03 WO disclosed
EP-3898636-B9 INDOLONAPHTHOPYRANS TRANSITIONS OPTICAL LTD (IE) 2023-11-08 EP disclosed
EP-3898636-B1 INDOLONAPHTHOPYRANS TRANSITIONS OPTICAL LTD (IE) 2023-08-30 EP disclosed
US-20230192908-A1 BIOMASS-DERIVED PHOTOINITIATORS BOWLING GREEN STATE UNIVERSITY (US) 2023-06-22 US disclosed
US-20220056039-A1 Indolonaphthopyrans TRANSITIONS OPTICAL, LTD. (IE) 2022-02-24 US disclosed
WO-2021236563-A1 BIOMASS-DERIVED PHOTOINITIATORS BOWLING GREEN STATE UNIVERSITY (US) 2021-11-25 WO disclosed
EP-3898636-A1 INDOLONAPHTHOPYRANS Transitions Optical, Ltd. (IE) 2021-10-27 EP disclosed
WO-2020126032-A1 INDOLONAPHTHOPYRANS TRANSITIONS OPTICAL, LTD. (IE) 2020-06-25 WO disclosed
EP-2078006-B1 PHOTOCHROMIC MATERIALS DEMONSTRATING IMPROVED FADE RATES TRANSITIONS OPTICAL INC (US) 2018-11-07 EP disclosed
US-9006427-B2 Photochromic materials demonstrating improved fade rates TRANSITIONS OPTICAL, INC. (US) 2015-04-14 US disclosed
US-8748634-B2 Photochromic materials demonstrating improved fade rates TRANSITIONS OPTICAL, INC. (US) 2014-06-10 US disclosed
US-20140155598-A1 PHOTOCHROMIC MATERIALS DEMONSTRATING IMPROVED FADE RATES TRANSITIONS OPTICAL, INC. (US) 2014-06-05 US disclosed
EP-2078006-A2 PHOTOCHROMIC MATERIALS DEMONSTRATING IMPROVED FADE RATES TRANSITIONS OPTICAL, INC. (US) 2009-07-15 EP disclosed
WO-2008054942-A2 PHOTOCHROMIC MATERIALS DEMONSTRATING IMPROVED FADE RATES TRANSITIONS OPTICAL, INC. (US) 2008-05-08 WO disclosed
US-20080103301-A1 PHOTOCHROMIC MATERIALS DEMONSTRATING IMPROVED FADE RATES TRANSITIONS OPTICAL, INC. (US) 2008-05-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080103301-A1 PHOTOCHROMIC MATERIALS DEMONSTRATING IMPROVED FADE RATES PNPO, FLAD1, CRY2 CYP1A2 159/4885CYP2C19 340/4885CYP3A4 333/4885
US-12344617-B2 Indolonaphthopyrans TPH1, TPH2, IDO1 CYP1A2 140/4885CYP2C19 496/4885CYP3A4 355/4885
US-20220056039-A1 Indolonaphthopyrans TPH1, TPH2, IDO1 CYP1A2 147/4885CYP2C19 421/4885CYP3A4 453/4885
US-20230192908-A1 BIOMASS-DERIVED PHOTOINITIATORS BLVRB, CYP1B1, GLB1 CYP1A2 39/4885CYP2C19 148/4885CYP3A4 30/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.